University of Illinois Chicago · Microbiology & ImmunologyRong Lab
Lijun Rong · Chicago, Illinois
Research Focus
The lab led by Dr. Lijun Rong at the University of Illinois at Chicago focuses on developing new antiviral therapies for Ebola viruses. They are working on optimizing small molecule inhibitors that could potentially treat or prevent infections caused by these highly dangerous viruses. Through innovative drug design and rigorous testing in animal models, the lab aims to provide effective options for combating Ebola virus disease.
Ebola virusantiviral therapysmall molecule inhibitorsdrug optimizationviral pathogenesis
Research Aims
3AIM 01Develop small molecule inhibitors for Ebola virus
AIM 02Optimize lead compounds using structure-based design
AIM 03Evaluate inhibitors in vivo using animal models
Skills the Lab Values
animal modelschemical optimizationdrug developmentin vitro assaysbinding assays
Output against the department
Publications196top 33% of dept.159th of 486
this lab
most publishedleast published
Citations5.7kbottom 43% of dept.277th of 486
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.